Literature DB >> 11250886

Vascular endothelial growth factor and the in vivo increase in plasma extravasation in the hamster cheek pouch.

M Félétou1, J Staczek, J Duhault.   

Abstract

1. The purpose of this study in the hamster cheek pouch was to determine whether or not vascular endothelial growth factor (VEGF) induced changes in plasma extravasation and if so, the mechanism(s) involved. 2. The cheek pouch microcirculatory bed of the anaesthetized hamster was directly observed under microscope and the number of vascular leakage sites, as shown by fluorescein isothiocyanate (FITC-dextran, 150 kD) extravasation, was counted. Drugs and VEGF were applied topically. VEGF from 0.05 to 0.5 microg ml(-1) (1.2 to 12 nM) produced a dose-dependent increase in the number of microvascular leakage sites from virtually none in basal conditions to up to 250 in some pouches. The effects of VEGF (0.1 microg ml(-1) or 2.4 nM) were blocked in a concentration-dependent manner by the non-specific heparin growth factor antagonist TBC-1635 (0.1, 1 and 3microM). The placenta growth factor (PlGF-1: 0.1 and 0.5 microg ml(-1) or 3.4 and 17 nM) did not increase plasma extravasation, per se, but abolished the effects of VEGF (2.4 nM). 3. The increases in microvascular leakage produced by VEGF (2.4 nM) were partially but significantly (P<0.05) inhibited by genistein (5 and 10 microM, up to 33% inhibition), LY 294002 (30 microM, 41%), bisindolylmaleimide (1 microM, 65%) and virtually abolished by indomethacin (3 microM, 88%) and L-nitro-arginine (10 microM, 95%), these drugs being inhibitors of tyrosine kinase, phosphatidylinositol-3-kinase, protein kinase C, cyclo-oxygenase and nitric oxide synthase respectively. None of these inhibitors, at the concentration tested, induced alone an increase in plasma extravasation. 4. These results indicate that the VEGF-induced plasma extravasation may involve the stimulation of VEGF-R2 (Flk-1/KDR) and the activation of phosphatidylinositol-3-kinase and protein kinase C. The production of both nitric oxide and prostaglandin is required to observe an increase in vascular leakage.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11250886      PMCID: PMC1572674          DOI: 10.1038/sj.bjp.0703941

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  50 in total

1.  Role of nitric oxide in modulating permeability of hamster cheek pouch in response to adenosine 5'-diphosphate and bradykinin.

Authors:  W G Mayhan
Journal:  Inflammation       Date:  1992-08       Impact factor: 4.092

2.  Aqueous smokeless tobacco extract impairs endothelium-dependent vasodilation in the oral mucosa.

Authors:  H Suzuki; X P Gao; C O Olopade; H A Jaffe; S Pakhlevaniants; I Rubinstein
Journal:  J Appl Physiol (1985)       Date:  1996-07

3.  Vascular endothelial growth factor/vascular permeability factor enhances vascular permeability via nitric oxide and prostacyclin.

Authors:  T Murohara; J R Horowitz; M Silver; Y Tsurumi; D Chen; A Sullivan; J M Isner
Journal:  Circulation       Date:  1998 Jan 6-13       Impact factor: 29.690

4.  Flt-1 but not KDR/Flk-1 tyrosine kinase is a receptor for placenta growth factor, which is related to vascular endothelial growth factor.

Authors:  A Sawano; T Takahashi; S Yamaguchi; M Aonuma; M Shibuya
Journal:  Cell Growth Differ       Date:  1996-02

5.  Vascular endothelial growth factor induces EDRF-dependent relaxation in coronary arteries.

Authors:  D D Ku; J K Zaleski; S Liu; T A Brock
Journal:  Am J Physiol       Date:  1993-08

6.  Bradykinin and changes in microvascular permeability in the hamster cheek pouch: role of nitric oxide.

Authors:  M Félétou; E Bonnardel; E Canet
Journal:  Br J Pharmacol       Date:  1996-07       Impact factor: 8.739

7.  Placenta growth factor. Potentiation of vascular endothelial growth factor bioactivity, in vitro and in vivo, and high affinity binding to Flt-1 but not to Flk-1/KDR.

Authors:  J E Park; H H Chen; J Winer; K A Houck; N Ferrara
Journal:  J Biol Chem       Date:  1994-10-14       Impact factor: 5.157

8.  Nitric oxide accounts for histamine-induced increases in macromolecular extravasation.

Authors:  W G Mayhan
Journal:  Am J Physiol       Date:  1994-06

9.  Platelet activating factor modulates microvascular permeability through nitric oxide synthesis.

Authors:  M M Ramírez; S M Quardt; D Kim; H Oshiro; M Minnicozzi; W N Durán
Journal:  Microvasc Res       Date:  1995-09       Impact factor: 3.514

10.  Platelet-activating factor stimulates protein tyrosine kinase in hamster cheek pouch microcirculation.

Authors:  D Kim; W N Durán
Journal:  Am J Physiol       Date:  1995-01
View more
  2 in total

1.  Nitrotyrosine, inducible nitric oxide synthase (iNOS), and endothelial nitric oxide synthase (eNOS) are increased in thyroid tumors from children and adolescents.

Authors:  A Patel; C Fenton; R Terrell; P A Powers; C Dinauer; R M Tuttle; G L Francis
Journal:  J Endocrinol Invest       Date:  2002-09       Impact factor: 4.256

2.  The plasma metabolome of women in early pregnancy differs from that of non-pregnant women.

Authors:  Samuel K Handelman; Roberto Romero; Adi L Tarca; Percy Pacora; Brian Ingram; Eli Maymon; Tinnakorn Chaiworapongsa; Sonia S Hassan; Offer Erez
Journal:  PLoS One       Date:  2019-11-14       Impact factor: 3.240

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.